Proclara Biosciences, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 8
Rang # Quantité totale PI 192 769
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 927 970
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

3 0
1 0
2 0
2
 
Dernier brevet 2019 - General amyloid interaction moti...
Premier brevet 2012 - Bacteriophage gene 3 protein com...
Dernière marque 2017 - Proclara BIOSCIENCES
Première marque 2016 - PROCLARA BIOSCIENCES

Industrie (Classification de Nice)

Derniers inventions, produits et services

2019 Invention General amyloid interaction motif (gaim). The present invention relates to variants of the genera...
2018 Invention Fusion proteins comprising p3 of bacteriophage. The invention relates to agents and to pharmaceut...
Invention Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenic...
2017 P/S Pharmaceutical preparations; pharmaceutical preparations for use in the prevention and treatment ...
2016 Invention Bacteriophage gene 3 protein compositions and use as amyloid binding agents. The invention relate...
2015 Invention Pure filamentous bacteriophage and methods of producing same. The invention relates to compositi...
Invention Polypeptides comprising a modified bacteriophage g3p amino acid sequence lacking a glycosylation ...